Adherium Announces Program with Vitalus Health on World Asthma Day
May 01, 2018 11:30 am UTC| Business
SAN MATEO, Calif., May 01, 2018 -- In conjunction with World Asthma Day, Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, announced today it has agreed to launch a...
Intellia Therapeutics Announces First Quarter 2018 Financial Results
May 01, 2018 11:30 am UTC| Business
New CEO puts in vivo and ex vivo genome editing on parallel tracks towards the clinic Company anticipates submitting its in vivo Investigational New Drug application by the end of 2019 for systemic lipid nanoparticle...
May 01, 2018 11:30 am UTC| Business
REDWOOD CITY, Calif., May 01, 2018 -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced that...
May 01, 2018 11:30 am UTC| Business
VANCOUVER, B.C., May 01, 2018 -- VR Resources Ltd. (TSX.V:VRR) (FSE:5VR) (OTCBB:VRRCF), the "Company", or “VR”, is pleased to announce the acquisition of the Kraut property, to expand its epithermal gold exploration...
KemPharm, Inc. to Report First Quarter 2018 Results
May 01, 2018 11:30 am UTC| Business
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for May 10, 2018, 4:30 p.m. ET CORALVILLE, Iowa, May 01, 2018 -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the...
Epizyme Announces First Quarter 2018 Financial Reporting Date and Upcoming Conference Call
May 01, 2018 11:30 am UTC| Business
First Quarter 2018 Financial Results to be Announced May 8, 2018 Investor Conference Call to be Scheduled for May 17, 2018 to Discuss Updated Interim Data from Tazemetostat Trials CAMBRIDGE, Mass., May 01, 2018 --...
Kura Oncology to Report First Quarter 2018 Financial Results
May 01, 2018 11:30 am UTC| Business
SAN DIEGO, May 01, 2018 -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it will report first quarter...